ResearcherFukushima Medical UniversityActive in the last 2 years
Rei Suzuki
Matched on ORCID iD 0000-0002-5093-6726; OpenAlex author ID A5103057376. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2012: 1 paper · 2013: 2 papers · 2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 2 papers · 2026: 1 paper
Papers 8
- Mortality and cancer risk in patients with chronic pancreatitis in japan: insights into the importance of surveillance for pancreatic cancer. Co-author DOI 10.1007/s00535-025-02321-0↗
- A Systemic Review and Meta-analysis of the Incidence Rate of Interstitial Lung Disease in Patients with Unresectable Pancreatic Cancer Treated with Gemcitabine… First author DOI 10.2169/internalmedicine.5084-24↗
- Development and Validation of a Nomogram of Predict Eligibility for Second-line Chemotherapy in Pancreatic Cancer. First author DOI 10.21873/anticanres.17798↗
- The role of endoscopic ultrasound in pancreatic cancer screening. Co-author DOI 10.4103/2303-9027.175876↗
- Preparation and evaluation of polyethyleneimine-single walled carbon nanotube conjugates as vectors for pancreatic cancer treatment. First author DOI 10.1039/c4tb00778f↗
- Pancreatic Cancer Screening: What We Do and Do Not Know Co-author DOI 10.1016/j.cgh.2013.02.004↗
- Endoscopic ultrasound-guided oncologic therapy for pancreatic cancer. Co-author DOI 10.1155/2013/157581↗
- Pancreatic cancer: early detection, diagnosis, and screening. Co-author DOI 10.1007/s12328-012-0327-0↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hiromasa Ohira · 3 shared papers, 2012–2025 · strength 0.50
- Paper A Systemic Review and Meta-analysis of the Incidence Rate of Interstitial Lung Disease in Patients with Unresectable Pa… DOI 10.2169/internalmedicine.5084-24↗
- Paper Development and Validation of a Nomogram of Predict Eligibility for Second-line Chemotherapy in Pancreatic Cancer. DOI 10.21873/anticanres.17798↗
- Paper Pancreatic cancer: early detection, diagnosis, and screening. DOI 10.1007/s12328-012-0327-0↗
- Hiroyuki Asama · 2 shared papers, 2025 · strength 0.46
- Paper A Systemic Review and Meta-analysis of the Incidence Rate of Interstitial Lung Disease in Patients with Unresectable Pa… DOI 10.2169/internalmedicine.5084-24↗
- Paper Development and Validation of a Nomogram of Predict Eligibility for Second-line Chemotherapy in Pancreatic Cancer. DOI 10.21873/anticanres.17798↗
- Mitsuru Sugimoto · 2 shared papers, 2025 · strength 0.46
- Paper A Systemic Review and Meta-analysis of the Incidence Rate of Interstitial Lung Disease in Patients with Unresectable Pa… DOI 10.2169/internalmedicine.5084-24↗
- Paper Development and Validation of a Nomogram of Predict Eligibility for Second-line Chemotherapy in Pancreatic Cancer. DOI 10.21873/anticanres.17798↗
- Hiroshi Shimizu · 2 shared papers, 2025 · strength 0.46
- Paper A Systemic Review and Meta-analysis of the Incidence Rate of Interstitial Lung Disease in Patients with Unresectable Pa… DOI 10.2169/internalmedicine.5084-24↗
- Paper Development and Validation of a Nomogram of Predict Eligibility for Second-line Chemotherapy in Pancreatic Cancer. DOI 10.21873/anticanres.17798↗
- Rei Ohira · 2 shared papers, 2025 · strength 0.46
- Paper A Systemic Review and Meta-analysis of the Incidence Rate of Interstitial Lung Disease in Patients with Unresectable Pa… DOI 10.2169/internalmedicine.5084-24↗
- Paper Development and Validation of a Nomogram of Predict Eligibility for Second-line Chemotherapy in Pancreatic Cancer. DOI 10.21873/anticanres.17798↗
- Kentaro Sato · 2 shared papers, 2025 · strength 0.46
- Paper A Systemic Review and Meta-analysis of the Incidence Rate of Interstitial Lung Disease in Patients with Unresectable Pa… DOI 10.2169/internalmedicine.5084-24↗
- Paper Development and Validation of a Nomogram of Predict Eligibility for Second-line Chemotherapy in Pancreatic Cancer. DOI 10.21873/anticanres.17798↗
- Manoop S. Bhutani · 5 shared papers, 2012–2016 · strength 0.27
- Yuichi Waragai · 1 shared paper, 2025 · strength 0.23
- Hiroki Irie · 1 shared paper, 2025 · strength 0.23
- Tadayuki J. Takagi · 1 shared paper, 2025 · strength 0.23
- Atsushi Irisawa · 3 shared papers, 2012–2016 · strength 0.17
- Paper The role of endoscopic ultrasound in pancreatic cancer screening. DOI 10.4103/2303-9027.175876↗
- Paper Endoscopic ultrasound-guided oncologic therapy for pancreatic cancer. DOI 10.1155/2013/157581↗
- Paper Pancreatic cancer: early detection, diagnosis, and screening. DOI 10.1007/s12328-012-0327-0↗
- Kenji Yamao · 1 shared paper, 2016 · strength 0.07
- Sushovan Guha · 1 shared paper, 2013 · strength 0.05
- Nirav C Thosani · 1 shared paper, 2013 · strength 0.05
- Enrico Andreoli · 1 shared paper, 2014 · strength 0.04
- Andrew R. Barron · 1 shared paper, 2014 · strength 0.04
- Jason B. Fleming · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.